David Henry Mack Pmv Pharmaceuticals, Inc. (PMVP) insider trading activity

PMVP Quotes by TradingView

David Henry Mack is President and CEO of PMV Pharmaceuticals, Inc.. Currently has a direct ownership of 442,460 shares of PMVP, which is worth approximately $721,209. The most recent transaction as insider was on Jan 18, 2024, when has been sold 163,890 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 442K
0% 3M change
21.6% 12M change
Total Value Held $721,209

David Henry Mack Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2024
BUY
Grant, award, or other acquisition
-
163,890 Added 27.03%
442,460 Common Stock
Nov 10 2023
SELL
Bona fide gift
-
85,307 Reduced 23.44%
278,570 Common Stock
Oct 18 2023
BUY
Exercise of conversion of derivative security
$105,155 $0.53 p/Share
198,407 Added 35.29%
363,877 Common Stock
Aug 07 2023
BUY
Exercise of conversion of derivative security
$45,315 $0.53 p/Share
85,500 Added 34.07%
165,470 Common Stock
Apr 27 2022
BUY
Exercise of conversion of derivative security
$17,490 $0.53 p/Share
33,000 Added 29.21%
79,970 Common Stock
Mar 08 2022
BUY
Exercise of conversion of derivative security
$27,400 $1.37 p/Share
20,000 Added 29.86%
46,970 Common Stock
Dec 15 2021
BUY
Exercise of conversion of derivative security
$4,770 $0.53 p/Share
9,000 Added 25.02%
26,970 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$2,915 $0.53 p/Share
5,500 Added 23.43%
17,970 Common Stock
Jul 21 2021
SELL
Open market or private sale
$957,188 $35.76 p/Share
26,767 Reduced 68.22%
12,470 Common Stock
Jul 21 2021
BUY
Exercise of conversion of derivative security
$14,187 $0.53 p/Share
26,767 Added 40.55%
39,237 Common Stock
Jul 20 2021
SELL
Open market or private sale
$36,560 $35.53 p/Share
1,029 Reduced 7.62%
12,470 Common Stock
Jul 20 2021
BUY
Exercise of conversion of derivative security
$545 $0.53 p/Share
1,029 Added 7.08%
13,499 Common Stock
Jun 28 2021
SELL
Open market or private sale
$7,248 $35.53 p/Share
204 Reduced 1.61%
12,470 Common Stock
Jun 28 2021
BUY
Exercise of conversion of derivative security
$108 $0.53 p/Share
204 Added 1.58%
12,674 Common Stock
May 21 2021
SELL
Open market or private sale
$221,652 $35.71 p/Share
6,207 Reduced 71.53%
2,470 Common Stock
May 21 2021
BUY
Exercise of conversion of derivative security
$3,290 $0.53 p/Share
6,207 Added 41.7%
8,677 Common Stock
May 20 2021
SELL
Open market or private sale
$277,431 $35.6 p/Share
7,793 Reduced 75.93%
2,470 Common Stock
May 20 2021
BUY
Exercise of conversion of derivative security
$5,300 $0.53 p/Share
10,000 Added 44.5%
12,470 Common Stock
May 20 2021
BUY
Exercise of conversion of derivative security
$4,130 $0.53 p/Share
7,793 Added 43.16%
10,263 Common Stock
Nov 18 2020
BUY
Exercise of conversion of derivative security
$1,309 $0.53 p/Share
2,470 Added 50.0%
2,470 Common Stock
DHM

David Henry Mack

President and CEO
Cranbury, NJ

Track Institutional and Insider Activities on PMVP

Follow PMV Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMVP shares.

Notify only if

Insider Trading

Get notified when an Pmv Pharmaceuticals, Inc. insider buys or sells PMVP shares.

Notify only if

News

Receive news related to PMV Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PMVP